"Amyloid beta-Peptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
| Descriptor ID |
D016229
|
| MeSH Number(s) |
D12.644.024 D12.776.049.407.249.500 D12.776.543.039.500
|
| Concept/Terms |
Amyloid beta-Peptides- Amyloid beta-Peptides
- Amyloid beta Peptides
- beta-Peptides, Amyloid
- Alzheimer's ABP
- ABP, Alzheimer's
- Alzheimer ABP
- Alzheimers ABP
- Alzheimer's Amyloid Fibril Protein
- Amyloid AD-AP
- AD-AP, Amyloid
- Amyloid AD AP
- beta-Amyloid Protein
- Protein, beta-Amyloid
- beta Amyloid Protein
- Amyloid beta-Protein
- Amyloid beta Protein
- beta-Protein, Amyloid
- Amyloid beta-Proteins
- Amyloid beta Proteins
- beta-Proteins, Amyloid
- Amyloid Fibril Protein, Alzheimer's
- Amyloid Protein A4
- Protein A4, Amyloid
- Alzheimer beta-Protein
- Alzheimer beta Protein
- beta-Protein, Alzheimer
- Amyloid beta-Peptide
- Amyloid beta Peptide
- beta-Peptide, Amyloid
|
Below are MeSH descriptors whose meaning is more general than "Amyloid beta-Peptides".
Below are MeSH descriptors whose meaning is more specific than "Amyloid beta-Peptides".
This graph shows the total number of publications written about "Amyloid beta-Peptides" by people in this website by year, and whether "Amyloid beta-Peptides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 5 | 0 | 5 |
| 2004 | 2 | 0 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 3 | 2 | 5 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2009 | 4 | 3 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 5 | 3 | 8 |
| 2012 | 4 | 0 | 4 |
| 2013 | 0 | 6 | 6 |
| 2014 | 4 | 3 | 7 |
| 2015 | 3 | 4 | 7 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 3 | 5 |
| 2018 | 3 | 2 | 5 |
| 2019 | 6 | 5 | 11 |
| 2020 | 3 | 4 | 7 |
| 2021 | 5 | 5 | 10 |
| 2022 | 1 | 8 | 9 |
| 2023 | 0 | 9 | 9 |
| 2024 | 4 | 8 | 12 |
| 2025 | 7 | 7 | 14 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloid beta-Peptides" by people in Profiles.
-
Condensate State as Determinant of Amyloid Pathology in Neurodegeneration. Biomolecules. 2026 Apr 10; 16(4).
-
The NIH toolbox emotion battery and cerebrospinal fluid biomarkers in Alzheimer's disease: findings from the multisite ARMADA study. J Gerontol B Psychol Sci Soc Sci. 2026 01 12; 81(2).
-
Concurrent detection of cognitive impairment and amyloid positivity with a multimodal machine learning-enabled digital cognitive assessment. Alzheimers Res Ther. 2025 Dec 11; 17(1):261.
-
Astrocytic Sox9 overexpression in Alzheimer's disease mouse models promotes A? plaque phagocytosis and preserves cognitive function. Nat Neurosci. 2026 Jan; 29(1):88-99.
-
Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test. Ann Clin Transl Neurol. 2026 Mar; 13(3):562-573.
-
Cognitive reserve predicts baseline tau burden in the U.S. POINTER trial imaging cohort. Alzheimers Dement. 2025 Nov; 21(11):e70892.
-
Apolipoprotein e4 exacerbates white matter impairment in a mouse model of A? amyloidosis by decreasing actively myelinating oligodendrocytes. Alzheimers Dement. 2025 Oct; 21(10):e70791.
-
PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia. Nature. 2025 10; 646(8087):1178-1186.
-
Altered Functional Connectivity and Amyloid Deposition in Posttraumatic Stress Disorder-Associated Cognitive Impairment. AJNR Am J Neuroradiol. 2025 Aug 01; 46(8):1660-1669.
-
Inhibition of the GSK3?/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitability. Alzheimers Dement. 2025 Jul; 21(7):e70507.